Vor Biopharma Inc reports results for the quarter ended in December - Earnings Summary

Vor Biopharma

23/03/2023 20:20

* Vor Biopharma Inc  VOR.OQ  reported a quarterly adjusted
loss
of 52 cents​​ per share for the quarter ended in December. The
mean expectation of eight analysts for the quarter was for a
loss of 60 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Vor Biopharma Inc's reported EPS for the quarter was a
loss
of 52 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Vor Biopharma Inc shares had fallen by 18.3% this quarter.
    * The company reported a quarterly loss of $23.91 million.
    * Wall Street's median 12-month price target for Vor
Biopharma Inc
is $17.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 23 at 08:20 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.60          -0.52          Beat
 Sep. 30 2022      -0.61          -0.63          Missed
 Jun. 30 2022      -0.66          -0.58          Beat
 Mar. 31 2022      -0.51          -0.61          Missed